Westpac Banking Corp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $215K | Sell |
|
|||||
|
2025
Q2 | $531K | Sell |
|
|||||
|
2025
Q1 | $474K | Sell |
|
|||||
|
2024
Q4 | $1.91M | Buy |
|
|||||
|
2024
Q3 | $1.45M | Buy |
|
|||||
|
2024
Q2 | $880K | Sell |
|
|||||
|
2024
Q1 | $936K | Hold |
|
|||||
|
2023
Q4 | $894K | Buy |
|
|||||
|
2023
Q3 | $223K | Sell |
|
|||||
|
2023
Q2 | $214K | Sell |
|
|||||
|
2023
Q1 | $718K | Hold |
|
|||||
|
2022
Q4 | $848K | Hold |
|
|||||
|
2022
Q3 | $754K | Hold |
|
|||||
|
2022
Q2 | $692K | Hold |
|
|||||
|
2022
Q1 | $665K | Hold |
|
|||||
|
2021
Q4 | $604K | Hold |
|
|||||
|
2021
Q3 | $681K | Hold |
|
|||||
|
2021
Q2 | $691K | Hold |
|
|||||
|
2021
Q1 | $690K | Hold |
|
|||||
|
2020
Q4 | $680K | Hold |
|
|||||
|
2020
Q3 | $682K | Hold |
|
|||||
|
2020
Q2 | $866K | Hold |
|
|||||
|
2020
Q1 | $614K | Hold |
|
|||||
|
2019
Q4 | $763K | Buy |
|